Immune and Opioid system interaction in pain modulation
Journal of Cellular & Molecular Anesthesia,
Vol. 4 No. 1 (2019),
15 August 2019
,
Page 24-30
https://doi.org/10.22037/jcma.v4i1.23728
Abstract
Background: Inflammatory pain is caused by direct stimulation of nociceptors with the release of inflammatory mediators. Several studies about the roles of immune and opioid systems in the pain process have suggested that their crosstalk may have effective in pain modulation. Accordingly, the purpose of this study was review the effect of immune and opioid systems on pain modulation.
Evidence acquisition: The increasing demand for mitigating inflammatory pain has led to the introduction of the effect of immune and opioid system interaction in pain modulation. Our literature reviewed 61 articles from 1991 to 2016.
Results: In this study, we reviewed most of the existing papers on the role of opioid system in pain modulation especially with a focus of the immune system efficacy. Our review suggested that there is a close correlation between the expression of cytokines and opioid receptors and in the process of inflammatory pain where immune cells have a notable effect on the expression of cytokines and opioid receptors. In the process of inflammation, different types of immune cells constitute a major source of opioid peptides. The endogenous opioids could modulate either their own secretion or secretion of other cytokines. They have also anti-nociceptive and anti-inflammatory effects.
Conclusion: Exacerbation of immune and opioid system reactions via correlation between cytokines and opioid peptides in the context of inflammatory pain arises the possibility of the role of interaction of these two important systems in the pain process.
Keywords: inflammatory pain, opioids, immune system, cytokines, hyperalgesia
- Nociceptors
- Inflammation Mediators
- Analgesics
- Opioid
- Immune System Process
- Cytokines
- Hyperalgesia
How to Cite
References
References
Gazerani S, Zaringhalam J, Manaheji H, Golabi S. The Role of C Fibers in Spinal Microglia Induction and Possible Relation with TRPV3 Expression During Chronic Inflammatory Arthritis in Rats. Basic Clin Neurosci. 2016;7(3):231–40.
Omoigui S. The biochemical origin of pain: The origin of all pain is inflammation and the inflammatory response. Part 2 of 3 - Inflammatory profile of pain syndromes. Med Hypotheses. 2007;69(6):1169–78.
Streit WJ, Mrak RE, Griffin WST. Microglia and neuroinflammation: A pathological perspective. J Neuroinflammation. 2004;1:1–4.
Barton GM. A calculated response: control of inflammation by the innate immune system. J Clin Invest. 2008;118(2):413–20.
Liang X, Liu R, Chen C, Ji F, Li T. Opioid System Modulates the Immune Function: A Review. 2016;1(1):5–13.
Zaringhalam J, Akbari A, Zali A, Manaheji H, Nazemian V, Shadnoush M, et al. Long-Term Treatment by Vitamin B1 and Reduction of Serum Proinflammatory Cytokines, Hyperalgesia, and Paw Edema in Adjuvant-Induced Arthritis. Basic Clin Neurosci J. 2016 ;7(4):331–40.
Nazemian V, Shadnoush M, Manaheji H, Zaringhalam J. Probiotics and Inflammatory Pain: A Literature Review Study. Middle East J Rehabil Heal. 2016;3(2):1–11.
Rittner HL, Stein C. Involvement of cytokines, chemokines and adhesion molecules in opioid analgesia. Eur J Pain. 2005;9(2):109–12.
Nasseri B, Nazemian V, Manaheji H, Zaringhalam J. Microglia are involve in pain related behaviors during the acute and chronic phase of arthritis inflammation. J Cell Mol Anesth. 2016;1(4):137–45.
Stein C, Schäfer M, Machelska H. Attacking pain at its source : new perspectives on opioids. 2003;9(8):1003–8.
De Jongh RF, Vissers KC, Meert TF, Booij LHDJ, De Deyne CS, Heylen RJ. The role of interleukin-6 in nociception and pain. Anesth Analg. 2003;96(4):1096–103
Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: Peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Vol. 361, Neuroscience Letters. 2004;361(1-3):184-7.
Junger H, Sorkin LS. Nociceptive and inflammatory effects of subcutaneous TNFα. Vol. 85, Pain. 2000;85(1-2):145-51
Conti P, Kempuraj D, Kandere K, Di Gioacchino M, Barbacane RC, Castellani ML, et al. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunology Letters. 2003. 123–9.
Tekieh E, Zaringhalam J, Manaheji H, Maghsoudi N, Alani B, Zardooz H. Increased serum IL-6 level time-dependently regulates hyperalgesia and spinal mu opioid receptor expression during CFA-induced arthritis. EXCLI J. 2011;10:23–33.
Boddeke EW. Involvement of chemokines in pain. Eur J Pharmacol. 2001;429(1-3):115–9.
Calvo M, Dawes JM, Bennett DLH. The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 2012;11(7):629–42.
Marchand F, Perretti M, Mcmahon SB. FO C U S O N PA I N ROLE OF THE IMMUNE SYSTEM IN CHRONIC PAIN. 2005;6(July):521–32.
Medzhitov R. Origin and physiological roles of inflammation.Nature. 2008;454(7203):428-35
Cai Z, Ratka A. Opioid system and Alzheimer’s disease. NeuroMolecular Med. 2012;14(2):91–111.
Le Merrer J, Becker JAJ, Befort K, Kieffer BL. Reward Processing by the Opioid System in the Brain. Physiol Rev. 2009;89(4):1379–412.
Melzack R. From the gate to the neuromatrix. Pain. 1999; 6:121–6.
Snyder SH, Childers SR. Opiate Receptors and Opioid Peptides. Annu Rev Neurosci. 1979;2(1):35–64.
Molaei M, Sanati MH, Zaringhalam J, Haghparast A. Microinjection of WIN55,212-2 as a cannabinoid agonist into the basolateral amygdala induces sensitization to morphine in rats. Basic Clin Neurosci. 2014;5(4):295–302.
Zaringhalam J, Manaheji H, Mghsoodi N, Farokhi B, Mirzaiee V. Spinal μ-opioid receptor expression and hyperalgesia with dexamethasone in chronic adjuvant-induced arthritis in rats. Clin Exp Pharmacol Physiol. 2008;35(11):1309–15.
Snyder SH, Pasternak GW. Historical review: Opioid receptors. Trends Pharmacol Sci. 2003;24(4):198–205.
GP Mcnally, H Akil.Opioid Peptides and Their Receptors: Overview and Function in Pain Modulation - Semantic Scholar. 2002.
Chapman CL, De Castro JM. Running addiction: measurement and associated psychological characteristics. J Sports Med Phys Fitness. 1990;30(3):283–90.
Przewłocki R. Some aspects of physiology and pharmacology of endogenous opioid peptides. Pol J Pharmacol Pharm. 1984;36(2-3):137–58.
Koltyn KF. Analgesia following exercise: a review. Sports Med. 2000;29(2):85–98.
Dalayeun JF, Norès JM, Bergal S. Physiology of beta-endorphins. A close-up view and a review of the literature. Biomed Pharmacother. 1993;47(8):311–20.
Mika J. The opioid systems and the role of glial cells in the effects of opioids. Advances in Palliative Medicine. 2008;7,185–196
Comb M, Seeburg PH, Adelman J, Eiden L, Herbert E. Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA. Nature. 1982;295(5851):663–6.
Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11(2):133–53.
Day R, Lazure C, Basak A, Boudreault A, Limperis P, Dong W, et al. Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activity. J Biol Chem. 1998;273(2):829–36.
Bruchas MR, Land BB, Chavkin C. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res. 2010;1314(1981):44–55.
Draisci G, Kajander KC, Dubner R, Bennett GJ, Iadarola MJ. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res. 1991;560(1-2):186–92.
Koneru A; Satyanarayana S; Rizman S. Endogenous Opioids : Their Physiological Role and Receptors. Glob J Pharmacol. 2009;3(3):149–53.
Zaringhalam J , Manaheji H , Maghsoodi N, Farokhi B , Mirzaee V. Investigation of the relation between the hypothalamus-pituitary-adrenal (HPA) axis activity, IL-6 and hyperalgesia during chronic inflammation due to rheumatoid arthritis (RA) in male rats. Physiol Pharmacol. 2007;11(2):130–6.
Zaringhalam J, Tekieh E, Manaheji H, Akhtari Z. Cellular events during arthritis-induced hyperalgesia are mediated by Interleukin-6 and p38 MAPK and their effects on the expression of spinal mu-opioid receptors. Rheumatol Int. 2013;33(9):2291–9.
Akhtari Z, Zaringhalam J, Eidi A, Manaheji H, Tekieh E. Bidirectional effects of serum TNF alpha level and spinal p38MAPK phosphorylation on hyperalgesia variation during CFA-induced arthritis. EXCLI J. 2012;11:373–85.
Zaringhalam J, Hormozi A, Tekieh E, Razavi J, Khanmohammad R, Golabi S. Serum IL-10 involved in morphine tolerance development during adjuvant-induced arthritis. J Physiol Biochem. 2014;70(2):497–507.
Vanderah TW. Delta and kappa opioid receptors as suitable drug targets for pain. Clin J Pain. 2010;26:10–5.
Rittner HL, Brack A, Stein C. Pain and the immune system. British Journal of Anaesthesia.2008;101(1):40–4
Nadal X, Baños J-E, Kieffer BL, Maldonado R. Neuropathic pain is enhanced in δ-opioid receptor knockout mice. Eur J Neurosci. 2006;23(3):830–4.
Gavériaux-Ruff C, Karchewski LA, Hever X, Matifas A, Kieffer BL. Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur J Neurosci. 2008;27(10):2558–67.
Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schäfer M, Loeffler JP, et al. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest. 1997;100(1):142–8.
Rachinger-Adam B, Conzen P, Azad SC. Pharmacology of peripheral opioid receptors. Curr Opin Anaesthesiol. 2011;24(4):408–13.
Kraus J, Orner CB, Giannini E, Ollt VH. The Role of Nuclear Factor kB in Tumor Necrosis Factor- Regulated Transcription of the Human µ-Opioid Receptor. Mol Pharmacol. 2003;64(4):876–84.
Sacerdote P. Opioids and the immune system. Palliat Med. 2006;20(1):9-15.
Rittner HL, Brack A, Stein C. Pain and the immune system. 2008;101(1):40–4.
Low HH. Receptor-Like lmmunoreactivities in Rat Dorsal Root Ganglia after Inflammation. J Neurosci. 1995; 15(12):8156-66.
Stanfa LC, Sullivan AF, Dickenson AH. Alterations in neuronal excitability and the potency of spinal mu , delta and kappa opioids after carrageenan-induced inflammation. Pain. 1992 ;50(3):345-54.
Receptors PO. Peripheral Opioid Receptors Mediating Evidence for Involvement Receptors Antinociception in of Mu , Delta and Kappa. J Pharmacol Exp Ther. 1989;248(3):1269-75.
Bidlack JM. Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol. 2000;7(5):719–23.
Nazemi S, Manaheji H, Noorbakhsh SM, Zaringhalam J, Sadeghi M, Mohammad-Zadeh M, et al. Inhibition of microglial activity alters spinal wide dynamic range neuron discharge and reduces microglial Toll-like receptor 4 expression in neuropathic rats. Clin Exp Pharmacol Physiol. 2015;42(7):772–9.
Nazemi S, Manaheji H, Zaringhalam J, Sadeghi M, Haghparast A. Post-injury repeated administrations of minocycline improve the antinociceptive effect of morphine in chronic constriction injury model of neuropathic pain in rat. Pharmacol Biochem Behav. 2012;102(4):520–5.
Watkins LR, Milligan ED, Maier SF. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol. 2003;521:1–21.
Watkins LR, Hutchinson MR, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF. Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun. 2007;21(2):131–46.
Nasseri B, Nazemian V, Manaheji H, Zaringhalam J. Microglia are involve in pain related behaviors during the acute and chronic phase of arthritis inflammation. J Cell Mol Anesth. 2016;1(4):137–45.
Zeinali H, Manaheji H, Zaringhalam J, Bahari Z, Nazemi S, Sadeghi M. Age-related differences in neuropathic pain behavior and spinal microglial activity after L5 spinal nerve ligation in male rats. Basic Clin Neurosci. 2016;7(3):203–12.
- Abstract Viewed: 301 times
- PDF Downloaded: 198 times